Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unresectable Biliary Tract Cancer × Immunotherapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 41 Melanoma 16 Neoplasm Metastasis 15 Lung Neoplasms 14 Neoplasms 11 Carcinoma, Hepatocellular 11 Esophageal Neoplasms 10 Colorectal Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Breast Neoplasms 7 Head and Neck Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Stomach Neoplasms 5 Rectal Neoplasms 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Recurrence 4 Carcinoma, Renal Cell 4 Brain Neoplasms 4 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Multiple Myeloma 3 Liver Neoplasms 3 Cholangiocarcinoma 3 Sarcoma 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pathologic Complete Response 2 Neuroblastoma 2 Neoplasm, Residual 2

Interventions

Immunotherapy 1 Gemcitabine 1 Cisplatin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06849193 2025-02-27

BTCICTY-001

Zhongda Hospital

Gastrointestinal

Unresectable Biliary Tract Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡